Loughborough, United Kingdom

Premji Meghani

USPTO Granted Patents = 40 

 

 

Average Co-Inventor Count = 4.6

ph-index = 8

Forward Citations = 202(Granted Patents)


Location History:

  • Leics, GB (1999)
  • Cheshire, GB (2014)
  • Leicestershire, GB (2010 - 2015)
  • Loughbourough, GB (2017)
  • Loughborough, GB (2000 - 2019)
  • Nottingham, GB (2016 - 2022)

Company Filing History:


Years Active: 1999-2022

Loading Chart...
Loading Chart...
Loading Chart...
40 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Premji Meghani

Premji Meghani, an accomplished inventor based in Loughborough, GB, has made significant contributions to the field of pharmaceutical innovation, holding an impressive 40 patents. His work primarily focuses on developing compounds with therapeutic applications, particularly in the area of inflammatory diseases.

Latest Patents

Among his latest inventions, Premji Meghani has developed inhibitors of plasma kallikrein. This invention provides various compounds that can be utilized in therapeutic settings for treating or preventing conditions associated with plasma kallikrein activity. Additionally, he has created kinase inhibitors, which demonstrate anti-inflammatory activity by inhibiting specific kinase enzymes. These compounds hold promise for use in treating a range of inflammatory diseases, including those affecting the lungs, eyes, and intestines.

Career Highlights

Premji Meghani's career includes notable positions at prominent pharmaceutical companies, including AstraZeneca and Topivert Pharma Limited. His expertise in medicinal chemistry and drug development has led to significant advancements in therapies aimed at mitigating inflammatory responses.

Collaborations

Throughout his career, Meghani has collaborated with distinguished colleagues, including Andrew Richard Novak and Marcus F Boehm. These partnerships have enhanced his research capabilities and innovation potential, leading to the creation of several ground-breaking therapeutic solutions.

Conclusion

In summary, inventor Premji Meghani has established himself as a leading figure in pharmaceutical innovation. His extensive patent portfolio and collaborative endeavors exemplify his dedication to advancing the medical field. With ongoing work in inhibitors and kinase compounds, Meghani continues to pave the way for future advancements in therapy and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…